Related Experiment Video
Updated: Jan 20, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
miR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer
1Department of Integrated Medicine, Affiliated to Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Abstract:
microRNA-496 (miR-496) was found expressed abnormally in non-small cell lung cancer (NSCLC). But the study about the role of miR-496 on NSCLC was not satisfactory in date. Therefore, here we designed to explore the role of miR-496 and the probable internal mechanism in tumorigenesis of NSCLC. Increasing miR-496 both in NSCLC patients and cell lines could significantly restrained cell proliferation. For farther researching the regulation mechanism of miR-496 on NSCLC, we screen Brain derived neurotrophic factor (BDNF) as a potential target of miR-496 by bioinformatic methods and predicted a possible target of miR-496 in the 3'untranslated region (UTR) of miR-496. In clinical patients and most NSCLC cell lines including H1650, H292, H1944 and A549, increasing expression of miR-496 suppressed tumor growth via inactivating BDNF-mediated PI3K/Akt signaling pathway activation. In a word, our fingdings first represent a mechanism of miR-496 on NSCLC tumor growth via inactivating BDNF-mediated PI3K/Akt signaling pathway.
Insights
MicroRNA-496 (miR-496) inhibits non-small cell lung cancer (NSCLC) growth by targeting Brain-Derived Neurotrophic Factor (BDNF). This study reveals miR-496
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Abnormal microRNA-496 (miR-496) expression is observed in non-small cell lung cancer (NSCLC).
- The precise role and mechanism of miR-496 in NSCLC tumorigenesis require further elucidation.
Purpose of the Study:
- To investigate the function of miR-496 in NSCLC development.
- To identify the molecular mechanism underlying miR-496's action in NSCLC.
Main Methods:
- Bioinformatic analysis was employed to identify potential targets of miR-496.
- The expression of miR-496 and its target were analyzed in NSCLC patients and cell lines.
- Functional assays were performed to assess the impact of miR-496 on cell proliferation and signaling pathways.
Main Results:
- Increased miR-496 expression significantly suppressed NSCLC cell proliferation in vitro and in vivo.
- Brain-Derived Neurotrophic Factor (BDNF) was identified as a direct target of miR-496.
- miR-496 inactivated the BDNF-mediated PI3K/Akt signaling pathway, thereby inhibiting tumor growth.
Conclusions:
- miR-496 functions as a tumor suppressor in NSCLC.
- The miR-496/BDNF axis plays a critical role in regulating NSCLC progression.
- Targeting miR-496 may represent a potential therapeutic strategy for NSCLC.
More Related Videos
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway